Appco Pharma LLC Issues Voluntary Nationwide Recall of Ranitidine Hydrochloride Capsules 150 mg and 300 mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

[ad_1]

Appco Pharma LLC (Appco) is voluntarily recalling all portions and plenty, inside expiry, of Ranitidine Hydrochloride Capsules to the Client degree. Ranitidine Hydrochloride Capsules are being recalled due to the presence or potential presence of N-nitrosodimethylamine (NDMA)

[ad_2]

Source link